Paediatric Infectious Diseases Unit, Department of Paediatrics, Hospital Gregorio Marañón, Madrid, Spain; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain; Department of Paediatrics, Infectious, and Tropical Diseases, Hospital La Paz, Madrid, Spain; Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Madrid, Spain.
J Hosp Infect. 2023 Sep;139:33-43. doi: 10.1016/j.jhin.2023.05.021. Epub 2023 Jun 16.
Antimicrobial resistance (AMR) has become a significant challenge in high-complexity healthcare settings.
To evaluate the prevalence of AMR in bloodstream isolates from high-complexity paediatric units in Spain over a nine-year period.
A retrospective observational multicentre study was conducted in three tertiary hospitals, analysing bloodstream isolates from patients aged <18 years admitted to the paediatric intensive care, neonatology, and oncology-haematology units between 2013 and 2021. Demographics, antimicrobial susceptibility, and resistance mechanisms were analysed in two periods (2013-2017 and 2017-2021).
In all, 1255 isolates were included. AMR was more prevalent in older patients and those admitted to the oncology-haematology unit. Multidrug resistance was observed in 9.9% of Gram-negative bacteria (GNB); 20.0% of P. aeruginosa vs 8.6% of Entero-bacterales (P < 0.001), with an increase in Enterobacterales from 6.2% to 11.0% between the first and the second period (P = 0.021). Difficult-to-treat resistance was observed in 2.7% of GNB; 7.4% of P. aeruginosa vs 1.6% of Enterobacterales (P < 0.001), with an increasing trend in Enterobacterales from 0.8% to 2.5% (P = 0.076). Carbapenem resistance among Enterobacterales increased from 3.5% to 7.2% (P = 0.029), with 3.3% producing carbapenemases (67.9% VIM). Meticillin resistance was observed in 11.0% of S. aureus and vancomycin resistance in 1.4% of Enterococcus spp., with both rates remaining stable throughout the study period.
This study reveals a high prevalence of AMR in high-complexity paediatric units. Enterobacterales showed a concerning increasing trend in resistant strains, with higher rates among older patients and those admitted to oncology-haematology units.
抗菌药物耐药性(AMR)已成为高复杂性医疗环境中的重大挑战。
评估西班牙高复杂性儿科病房中血流感染分离株在 9 年内 AMR 的流行情况。
对三家三级医院进行了回顾性观察性多中心研究,分析了 2013 年至 2021 年间在儿科重症监护、新生儿科和肿瘤-血液科病房住院的<18 岁患者的血流分离株。对两个时期(2013-2017 年和 2017-2021 年)的人口统计学、抗微生物药物敏感性和耐药机制进行了分析。
共纳入 1255 株分离株。年龄较大的患者和入住肿瘤-血液科病房的患者 AMR 更为普遍。革兰氏阴性菌(GNB)中观察到多重耐药性为 9.9%;铜绿假单胞菌为 20.0%,肠杆菌科为 8.6%(P<0.001),第一个时期和第二个时期肠杆菌科从 6.2%增加到 11.0%(P=0.021)。在 GNB 中观察到难以治疗的耐药性为 2.7%;铜绿假单胞菌为 7.4%,肠杆菌科为 1.6%(P<0.001),肠杆菌科呈上升趋势,从 0.8%增加到 2.5%(P=0.076)。肠杆菌科中的碳青霉烯类耐药性从 3.5%增加到 7.2%(P=0.029),有 3.3%产生碳青霉烯酶(67.9%为 VIM)。金黄色葡萄球菌的耐甲氧西林率为 11.0%,肠球菌属的万古霉素耐药率为 1.4%,这两个比率在整个研究期间保持稳定。
本研究揭示了高复杂性儿科病房中 AMR 的高流行率。肠杆菌科中耐药菌株呈令人担忧的上升趋势,老年患者和入住肿瘤-血液科病房的患者比例更高。